AbelZeta Pharma

Board of Directors

TONY (BIZUO) LIU

CHAIRMAN & CEO

Mr Liu joined AbelZeta in 2013 as Chairman of the Audit Committee. Subsequently, Mr Liu joined the company as Chief Financial Officer in 2014 and was appointed Chief Executive Officer in February 2016.

From 2009 to 2012, Mr. Liu served as the Corporate Vice President at Alibaba Group, leading B2B corporate investment, and corporate finance, and served as General Manager for the B2C international e-commerce platform “AliExpress” and led Alibaba’s overseas investments. From 2012 to 2014, Mr Liu was Chief Financial Officer for Alibaba’s subsidiary HiChina, a leading internet infrastructure service provider.

Prior to joining Alibaba Group, Mr Liu spent 19 years at Microsoft Corporation in Seattle, where he served in leadership roles with progressive responsibilities from Corporate Accounting Director, Microsoft China CFO, to General Manager of Corporate Strategy, leading Microsoft’s China investment strategy and Microsoft global strategic planning process.

Mr. Liu holds a Bachelor of Science in Physics from Suzhou University, China.

EDWARD SCHAFER

Director

Mr. Schafer has been a director of the Company since October 2019. He has served on audit and compensation committees for public companies and has deep experience in strategic planning in both the private and public sectors. Mr. Schafer has served as Vice Chairman of Bion Environmental Technologies Inc., an agriculture technology company, since 2011. Mr. Schafer is Co-Founder of Extend America, a rural America wireless communication company. He is a board member of AGCO-Amity JV, and Vice Chairman of Amity Technology LLP, agricultural equipment companies, and previously served on the board of NorthStar Capital Partners LLC, a financial services company. Mr. Schafer is also Chairman of Dynamic Food Ingredients, and a board member of the Center for Innovation at the University of North Dakota and teaches a leadership class at North Dakota State University. Mr. Schafer was elected as governor of the State of North Dakota in two consecutive terms, is a past chair of the Republican Governors Association, the Midwestern Governors’ Association, the Interstate Oil and Gas Compact, the Western Governors’ Association and served as the 29th United States Secretary of Agricultural from 2008 to 2009.

Mr. Schafer holds a master’s degree in business administration from the University of Denver. In considering Mr. Schafer’s eligibility to serve on the Board, the Board considered Mr. Schafer’s business acumen, administration and management experience in the public and private sectors.

XIAO (ALBERT) HUANG, Ph.D.

Director

Dr. Huang has been a director of the Company since 2021. He has served as Managing Director at YF Capital since 2015, focused on biopharmaceuticals, gene sequencing and medical devices. From 2011 to 2015 he served as Project Leader at The Boston Consulting Group (BCG).

Dr. Huang received his bachelor’s degree in biological sciences from Tsinghua University and his Ph.D. in biopharmaceuticals from Yale University. He is also the current Secretary General of Tsinghua biomedicine Yangtze River Delta (Y.R.Delta) Alumni Association.

WEI CHENG PhD

Director

Dr. Cheng has been a director of the Company since 2021. She has been a Partner at TF Capital since July 2023, following managing and senior director positions from 2020 to 2023. Prior to joining TF Capital, Dr. Cheng served as Investment Director at Legend Star from 2019 to 2020, and as Senior Vice President of Investment/Executive Director of Healthcare Fund at TH Capital from 2018 to 2019.

Dr. Cheng received her bachelor’s degree, Biological Science and Biotechnology, from Tsinghua University, and received her doctorate degree, Neuroscience, RNAi from UMass Chan Medical School.

Scroll to Top